CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE: Release of a capital market information
CompuGroup Medical SE / Share Buyback 30.07.2018 / 09:25 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 2nd Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, July 30, 2018 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 2nd Interim Announcement In the period from July 23, 2018, up to and including July 27, 2018, CompuGroup Medical SE has bought back a total of 29,383 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018. The overall volume of the shares bought back daily in the period from July 23, 2018, up to and including July 27, 2018, and the daily volume-weighted average stock market prices of the shares are as follows:Date Overall volume of Volume-weighted average stock shares bought back market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) July 23, 2018 5,053 46.6099 July 24, 2018 5,412 47.5818 July 25, 2018 4,891 47.8314 July 26, 2018 6,827 48.5810 July 27, 2018 7,200 48.7084 In total: 29,383 47.9644The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including July 27, 2018, within the framework of the share buyback program thus amounts to 69,659 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, July 30, 2018 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 --------------------------------------------------------------------------- 30.07.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Internet: www.cgm.com End of News DGAP News Service
Aktuelle News
Aktuelle Berichte
Anstehende Events
Events Funktionen
Weitere Funktionen
Webcasts
Keine Webcasts gefunden